The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A practical view of ‘druggability’
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus
Erbel, P., Schiering, N., D'Arcy, A., Renatus, M., Kroemer, M., Lim, S. P., Yin, Z., Keller, T. H., Vasudevan, S. G., & Hommel, U. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1073 · Cited by 583
Self-citationA Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 522
The druggable genome: an update
Russ, A. P., & Lampel, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03666-4 · Cited by 424
Selection criteria for drug‐like compounds
Muegge, I. (2003) · Medicinal Research Reviews · doi:10.1002/med.10041 · Cited by 412
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
Vieth, M., Siegel, M. G., Higgs, R. E., Watson, I. A., Robertson, D. H., Savin, K. A., Durst, G. L., & Hipskind, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030267j · Cited by 359
Drug research: myths, hype and reality
Kubinyi, H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1156 · Cited by 348
Fragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
Utility of homology models in the drug discovery process
Hillisch, A., Pineda, L. F., & Hilgenfeld, R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03196-4 · Cited by 310
Predicting protein druggability
Hajduk, P. J., Huth, J. R., & Tse, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03624-x · Cited by 289
Library Design for Fragment Based Screening
Schuffenhauer, A., Ruedisser, S., Marzinzik, A., Jahnke, W., Selzer, P., & Jacoby, E. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054637700 · Cited by 203
sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank
Kellenberger, E., Muller, P., Schalon, C., Bret, G., Foata, N., & Rognan, D. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050372x · Cited by 201
Comprehensive identification of "druggable" protein ligand binding sites.
An, J., Totrov, M. M., & Abagyan, R. A. (2004) · PubMed · Cited by 117
Characterization of protein-ligand interaction sites using experimental and computational methods.
Vajda, S., & Guarnieri, F. (2006) · PubMed · Cited by 109
Molecular properties that influence oral drug-like behavior.
Lajiness, M. S., Vieth, M., & Erickson, J. A. (2004) · PubMed · Cited by 102
Screening Drug-Like Compounds by Docking to Homology Models: A Systematic Study
Kairys, V., Fernandes, M. X., & Gilson, M. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050238c · Cited by 91
Assessment of chemical libraries for their druggability
Sirois, S., Hatzakis, G., Wei, D., Du, Q.-S., & Chou, K. (2005) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2004.11.003 · Cited by 63
Effects of Conformational Dynamics on Predicted Protein Druggability
Brown, S. P., & Hajduk, P. J. (2006) · ChemMedChem · doi:10.1002/cmdc.200500013 · Cited by 59
The promise of genomics to identify novel therapeutic targets
Orth, A. P., Batalov, S., Perrone, M. H., & Chanda, S. K. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.587 · Cited by 56
Current trends in lead discovery: Are we looking for the appropriate properties?
Oprea, T. I. (2000) · Molecular Diversity · doi:10.1023/a:1021368007777 · Cited by 54
Capter 11 Filtering in Drug Discovery
Lipinski, C. A. (2005) · Annual reports in computational chemistry · doi:10.1016/s1574-1400(05)01011-x · Cited by 49
How many genomics targets can a portfolio afford?
Betz, U. A. K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03498-7 · Cited by 44
Druggability: selecting optimized drug candidates
Sugiyama, Y. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03675-5 · Cited by 37
Rothberg, B. E. G., Peña, C. E., & Rothberg, J. M. (2005) · Wiley eBooks · doi:10.1002/9783527620982.ch4 · Cited by 6
Cited by
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
Newman, D. J., & Cragg, G. M. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01285 · Cited by 7,015
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Metadata
- Authors
- Keller, T. H., Pichota, A., & Yin, Z.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 10
- Issue
- 4
- Pages
- 357-361
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2054912906
- Cited by
- 295
- References
- 34
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.